Pharmaceutical Executive
December 20, 2006
0
0
Analysts say Times' accusatory articles on Zyprexa are nothing to get excited about.
December 20, 2006
0
0
FDA's revisions to guidelines on expanding access to experimental drugs intensify an already murky issue for pharma.
December 20, 2006
0
0
At its annual pipeline debut, the company introduced its own CETP-inhibitor--with doubts.